TLR

(redirected from Toll like receptor)
Also found in: Dictionary, Medical.
AcronymDefinition
TLRTrailer
TLRToll Like Receptor (immunological research)
TLRTwin Lens Reflex
TLRTemple (University) Law Review
TLRTeam Losi Racing (est. 1980)
TLRTailor
TLRTarget Lesion Revascularization
TLRTiller
TLRTo Love Ru (Japanese manga series)
TLRThe Last Resort (gaming clan)
TLRTransmission Loading Relief
TLRTexas Law Review
TLRTemplar (gaming guild)
TLRTonic Labyrinthine Reflex
TLRTeaching and Learning Responsibilities (UK educational initiative and job role)
TLRTime Lapse Recorder
TLRTilburg Law Review (Tilburg University; Tilburg, Netherlands)
TLRTotal Loss Replacement
TLRThe Last Resistance (gaming clan)
TLRThe Last Royals (band)
TLRThomson Legal & Regulatory Ltd. (Australia)
TLRTriangulation-Listening-Ranging (sonar; US Navy)
TLRThanet Local Radio (UK)
TLRTransportation Librarians Roundtable (US Department of Transportation)
TLRtarget loss ratio
TLRTop Level Requirement(s)
TLRTransmission-Line Resonator
TLRTwo Lochs Radio (UK, Scotland)
TLRThe Lord Reigns
TLRTechnical Letter Report
TLRTelecommunications Leasing Request
TLRTermination Liability Reserve
TLRTransport Layer Retry
TLRTennis Live Radio
TLRTraceability Link Recovery
TLRTeam Lost Rebels
References in periodicals archive ?
Boumpas, "Toll like receptors and autoimmunity: a critical appraisal," Journal ofAutoimmunity, vol.
Washington, Sep 3 (ANI): A new research has discovered that males with a variant form of the immune receptor gene 'Toll Like Receptor 7 (TLR7)' are more likely to develop the autoimmune disease systemic lupus erythematosus (lupus).
Because inflammation aggravates atherosclerosis, a muted inflammatory response in people with the variant form of the toll like receptor 4 gene may limit plaque accumulation, Schwartz says.
A frequent functional toll like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.
Pasterkamp, "Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness," Atherosclerosis, vol.
Seshadri, "Understanding and modulating the toll like receptors (TLRs) and NOD like receptors (NLRs) cross talk in type 2 diabetes," Current Diabetes Reviews, vol.